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Since 1982, one century after the discovery of Myco-
bacterium tuberculosis as the causal agent of the disease 
by Robert Koch in Berlin, on March 24th each year the 
World Health Organization (WHO) celebrates the World 
TB day.
This event aims to raise people awareness about the bur-
den of tuberculosis (TB) and the status of TB prevention 
and to spur social and political stakeholders to make fur-
ther efforts and work together in strong partnerships to 
stop TB at all levels [1].
The global end TB strategy 2016-2035 and the WHO 
global TB programme develop policies, strategies and 
standards, assess national programme performances and 
facilitate partnerships and communication to advance 
universal access to TB prevention, care and control.
The global TB report 2019 showed that the world didn’t 
reach 2019 goal in stop TB, and that multidrug resistant 
TB is still spread in many countries in the world.
TB is one of the top 10 causes of death worldwide, kill-
ing over 4.500 people every day [2]. In 2018, there were 
an estimated 10 million new TB cases worldwide.
There were an estimated 1.2 million TB deaths among 
HIV-negative people in 2018, and an additional 251.000 
among HIV-positive people; 57% of all TB cases were 
in men in 2018.
Geographically, most TB cases in 2018 were in the 
WHO Regions of South-East Asia (44%), Africa (24%) 
and the Western Pacific (18%) [2].
Moreover, the social and economic impacts of tuber-
culosis worldwide are devastating, including poverty, 
stigma and discrimination.
On 26 september 2018, the first hig-level meeting of 
the United Nations General Assembly (UNHLM) on 
the fight against tuberculosis brought together Heads of 
State under the theme “United to end tuberculosis: an ur-
gent global response to a global epidemic”, with support 
of WHO and other international organizations. 
The meeting resulted in an action-oriented political dec-
laration, builds on previous commitments in the Mos-
cow declaration to End TB, that will strenghten action 
and investments towards the end TB response [3].
The end TB strategy adopted by the WHO in 2014 aims 
to end the global TB epidemic and to remove catastroph-
ic costs for TB-affected households by 2030, to reduce 
deaths about 90% and TB incidence of 80%.
The 2020 theme for stop TB day, “It’s time!”, highlights 
the timely need for action in scale up, research, funding, 
human rights and accountability [4].
Main goals are:
• improve access to prevention and treatment of tuber-
culosis;
• grant for research;
• stop discrimination of illness people.
In 2018, 484.000 people developed a drug-resistant tu-
berculosis; in these cases treatment success rate was low 
globally, with a mean of 56% [2].
Drug resistant TB remains a public health problem with 
gaps in detection and treatment: in 2016 490.000 people 
developed a multi-drug resistant TB worldwide, and oth-
er 110.000 people were affected by rifampicin-resistant 
TB and required second-line treatment [5].
From 2000 to 2016, however, about 53 million people 
were saved, also thanks to a great effort organized and 
carried out worldwide, that permitted to reduce the mor-
tality rate by 42%.
Every year, during the World TB Day, WHO together 
with the Global Fund and Stop TB Partnership highlights 
to governments, communities, civil society organiza-
tions, health care providers and national / international 
partners the need to join forces under the slogan “Find. 
Treat. All. #EndTB” to guarantee assistance to millions 
of people who do not have access to quality care.
United Nations member states committed to fulfilling 
the following key targets by 2022: successfully treat 40 
million people with TB, including 3.5 million children 
(under 15 years of age), successfully treat 1.5 million 
people with multidrug-resistant TB, including 115.000 
children, provide TB preventive therapy for at least 30 
million people, including 4 million children under the 
age of 5, 20 million other household contacts of people 
affected by TB, and 6 million people living with HIV [6].
Moreover, stakeholders will try to increase global invest-
ment in TB prevention, diagnosis, treatment and care to 
US$ 13 billion annually [4].
A strong support for research, innovation and develop-
ment is needed by 2025, in order to reach an annual de-
cline in the global TB incidence rate of 17% per year.
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Principal targets are to discover a vaccine to lower the risk 
of infection, or new drug treatment to cut the risk of TB dis-
ease in the 1.7 billion people already latently infected [2].
Only by reinforcing a joint response, it is possible for the 
world to reach the commitments established by the End 
TB strategy, WHO and Stop TB Global Plan.
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